Abstract
Aims
This study aimed to compare the efficacy and safety of pre-operative and post-operative meloxicam administration regarding post-operative pain control and knee joint function recovery in knee osteoarthritis (KOA) patients who underwent total knee arthroplasty (TKA).
Methods
Totally, 196 KOA patients who underwent TKA were consecutively enrolled and randomly assigned into pre-operative (N = 98) and post-operative administration group (N = 98) as 1:1 ratio. Pre-operative administration group received meloxicam 15 mg at 24 h pre-operation and 7.5 mg at 4 h, 24 h, 48 h, and 72 h post-operation, respectively. Post-operative administration group received meloxicam 15 mg at 4 h post-operation and 7.5 mg at 24 h, 48 h, and 72 h post-operation, respectively. Pain visual analog scale (VAS) at rest and at flexion, patient’s global assessment (PGA), patient-controlled analgesia (PCA) consumption, hospital for special surgery (HSS), knee score, and adverse events were assessed.
Results
Pre-operative meloxicam administration attenuated pain VAS score at rest at 6 h, 12 h, and 24 h; and pain VAS score at flexion at 6 h, 12 h, 24 h, and 48 h; as well as PGA score at 6 h, 12 h, 48 h post-TKA compared with post-operative meloxicam administration. Additional and total consumption of PCA were both decreased in pre-operative meloxicam administration group than post-operative meloxicam administration group, while HSS knee score at 3 months post-TKA was similar between pre-operative and post-operative meloxicam administration groups. Regarding safety, the incidence of adverse events was of no difference between the two groups.
Conclusion
Pre-operative administration of meloxicam might assist the post-operative pain management and care in KOA patients who underwent TKA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT Jr (2019) Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol 15(2):77–90. https://doi.org/10.1038/s41584-018-0123-4
Hunter DJ, Bierma-Zeinstra S (2019) Osteoarthritis. Lancet 393(10182):1745–1759. https://doi.org/10.1016/S0140-6736(19)30417-9
Madaleno FO, Santos BA, Araujo VL, Oliveira VC, Resende RA (2018) Prevalence of knee osteoarthritis in former athletes: a systematic review with meta-analysis. Braz J Phys Ther. https://doi.org/10.1016/j.bjpt.2018.03.012
Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, Holt HL, Solomon DH, Yelin E, Paltiel AD, Katz JN (2009) Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med 169(12):1113–1121; discussion 1121-1112. https://doi.org/10.1001/archinternmed.2009.136
Clarke H, Pereira S, Kennedy D, Gilron I, Katz J, Gollish J, Kay J (2009) Gabapentin decreases morphine consumption and improves functional recovery following total knee arthroplasty. Pain Res Manag 14(3):217–222
Bruyere O, Honvo G, Veronese N, Arden NK, Branco J, Curtis EM, Al-Daghri NM, Herrero-Beaumont G, Martel-Pelletier J, Pelletier JP, Rannou F, Rizzoli R, Roth R, Uebelhart D, Cooper C, Reginster JY (2019) An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. https://doi.org/10.1016/j.semarthrit.2019.04.008
Gaffney CJ, Pelt CE, Gililland JM, Peters CL (2017) Perioperative Pain Management in Hip and Knee Arthroplasty. Orthop Clin North Am 48(4):407–419. https://doi.org/10.1016/j.ocl.2017.05.001
McDonald LT, Corbiere NC, DeLisle JA, Clark AM, Kuxhaus L (2016) Pain Management After Total Joint Arthroplasty. AORN J 103(6):605–616. https://doi.org/10.1016/j.aorn.2016.04.003
Bergese SD, Melson TI, Candiotti KA, Ayad SS, Mack RJ, McCallum SW, Du W, Gomez A, Marcet JE (2019) A Phase 3, Randomized, Placebo-Controlled Evaluation of the Safety of Intravenous Meloxicam Following Major Surgery. Clin Pharmacol Drug Dev. https://doi.org/10.1002/cpdd.666
Smith HS, Baird W (2003) Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population. Am J Hosp Palliat Care 20(4):297–306. https://doi.org/10.1177/104990910302000413
Bekker A, Kloepping C, Collingwood S (2018) Meloxicam in the management of post-operative pain: Narrative review. J Anaesthesiol Clin Pharmacol 34(4):450–457. https://doi.org/10.4103/joacp.JOACP_133_18
Aghadavoudi O, Saryazdi HH, Shafa A, Ramezani A (2015) Comparison of Pre-Emptive Effect of Meloxicam and Celecoxcib on Post-Operative Analgesia: A Double-Blind, Randomized Clinical Trial. Middle East J Anaesthesiol 23(3):289–294
Thompson JP, Sharpe P, Kiani S, Owen-Smith O (2000) Effect of meloxicam on postoperative pain after abdominal hysterectomy. Br J Anaesth 84(2):151–154
Orozco-Solis M, Garcia-Avalos Y, Pichardo-Ramirez C, Tobias-Azua F, Zapata-Morales JR, Aragon-Martinez OH, Isiordia-Espinoza MA (2016) Single dose of diclofenac or meloxicam for control of pain, facial swelling, and trismus in oral surgery. Med Oral Patol Oral Cir Bucal 21(1):e127–e134. https://doi.org/10.4317/medoral.20925
Calvo AM, Sakai VT, Giglio FP, Modena KC, Colombini BL, Benetello V, Sakamoto FC, Freire TM, Dionisio TJ, Lauris JR, Trindade AS Jr, Faria FA, Santos CF (2007) Analgesic and anti-inflammatory dose-response relationship of 7.5 and 15 mg meloxicam after lower third molar removal: a double-blind, randomized, crossover study. Int J Oral Maxillofac Surg 36(1):26–31. https://doi.org/10.1016/j.ijom.2006.09.006
Liu J, Wang F (2018) Preoperative celecoxib analgesia is more efficient and equally tolerated compared to postoperative celecoxib analgesia in knee osteoarthritis patients undergoing total knee arthroplasty: A randomized, controlled study. Medicine (Baltimore) 97(51):e13663. https://doi.org/10.1097/MD.0000000000013663
Gates BJ, Nguyen TT, Setter SM, Davies NM (2005) Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety. Expert Opin Pharmacother 6(12):2117–2140. https://doi.org/10.1517/14656566.6.12.2117
Kurukahvecioglu O, Karamercan A, Ege B, Koksal H, Anadol Z, Tezel E, Ersoy E (2007) Effect of meloxicam on postoperative pain relief after inguinal hernia repair with local anaesthesia. West Indian Med J 56(6):530–533
Colloca L, Klinger R, Flor H, Bingel U (2013) Placebo analgesia: psychological and neurobiological mechanisms. Pain 154(4):511–514. https://doi.org/10.1016/j.pain.2013.02.002
Turck D, Busch U, Heinzel G, Narjes H (1997) Clinical pharmacokinetics of meloxicam. Arzneimittelforschung 47(3):253–258
Yocum D, Fleischmann R, Dalgin P, Caldwell J, Hall D, Roszko P (2000) Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators. Arch Intern Med 160(19):2947–2954
Zeidler H, Kaltwasser JP, Leonard JP, Kohlmann T, Sigmund R, Degner F, Hettich M (2002) Prescription and tolerability of meloxicam in day-to-day practice: postmarketing observational cohort study of 13,307 patients in Germany. J Clin Rheumatol 8(6):305–315
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shao, Y., Zhao, X., Zhai, Y. et al. Comparison of analgesic effect, knee joint function recovery, and safety profiles between pre-operative and post-operative administrations of meloxicam in knee osteoarthritis patients who underwent total knee arthroplasty. Ir J Med Sci 189, 535–542 (2020). https://doi.org/10.1007/s11845-019-02128-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-019-02128-y